The reversal-resorption phase is further extended in glucocorticoid-induced osteoporosis compared to postmenopausal controls and osteoporotic patients

被引:0
|
作者
Thomsen, Lisbeth Koch [1 ,2 ]
Kejser, Majken I. [1 ,2 ]
Sorensen, Line L. [1 ,2 ]
Jensen, Pia R. [3 ]
Hauge, Ellen-Margrethe [4 ]
Bollerslev, Jens [5 ]
Boel, Lene W. T. [6 ]
Delaisse, Jean-Marie [1 ,2 ]
Andreasen, Christina M. [1 ,2 ]
Andersen, Thomas L. [1 ,2 ]
机构
[1] Odense Univ Hosp, Dept Clin Pathol, Clin Cell Biol, Odense, Denmark
[2] Univ Southern Denmark, Dept Mol Med, Dept Clin Res, Res Unit Pathol, Odense, Denmark
[3] Univ Southern Denmark, Vejle Hosp, IRS, Dept Clin Cell Biol KCB, Odense, Denmark
[4] Aarhus Univ Hosp, Dept Rheumatol, Aarhus, Denmark
[5] Oslo Univ Hosp, Sect Specialized Endocrinol, Med Clin B, Oslo, Norway
[6] Univ Oslo, Fac Med, Oslo, Norway
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P-498
引用
收藏
页码:202 / 202
页数:1
相关论文
共 5 条
  • [1] THE COMPARATIVE EFFICIENCY OF DENOSUMAB TREATMENT IN PATIENTS WITH POSTMENOPAUSAL OSTEOPOROSIS, PRIMARY HYPERPARATHYROIDISM AND GLUCOCORTICOID-INDUCED OSTEOPOROSIS IN REAL CLINICAL PRACTICE
    Rozhinskaya, L.
    Gronskaya, S.
    Mamedova, E.
    Belaya, Z.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S186 - S186
  • [2] The cost effectiveness of teriparatide as a first-line treatment for glucocorticoid-induced and postmenopausal osteoporosis patients in Sweden
    Murphy, Daniel R.
    Smolen, Lee J.
    Klein, Timothy M.
    Klein, Robert W.
    BMC MUSCULOSKELETAL DISORDERS, 2012, 13
  • [3] The cost effectiveness of teriparatide as a first-line treatment for glucocorticoid-induced and postmenopausal osteoporosis patients in Sweden
    Daniel R Murphy
    Lee J Smolen
    Timothy M Klein
    Robert W Klein
    BMC Musculoskeletal Disorders, 13
  • [4] Denosumab is effective toward glucocorticoid-induced osteoporosis patients complicated with rheumatic diseases regardless of prior anti-osteoporotic drugs
    Naoki Iwamoto
    Momoko Okamoto
    Sosuke Tsuji
    Yushiro Endo
    Ayuko Takatani
    Toshimasa Shimizu
    Masataka Umeda
    Shoichi Fukui
    Remi Sumiyoshi
    Takashi Igawa
    Tomohiro Koga
    Shin-ya Kawashiri
    Toshiyuki Aramaki
    Kunihiro Ichinose
    Mami Tamai
    Hideki Nakamura
    Tomoki Origuchi
    Katsumi Eguchi
    Yukitaka Ueki
    Atsushi Kawakami
    Journal of Bone and Mineral Metabolism, 2019, 37 : 554 - 562
  • [5] Denosumab is effective toward glucocorticoid-induced osteoporosis patients complicated with rheumatic diseases regardless of prior anti-osteoporotic drugs
    Iwamoto, Naoki
    Okamoto, Momoko
    Tsuji, Sosuke
    Endo, Yushiro
    Takatani, Ayuko
    Shimizu, Toshimasa
    Umeda, Masataka
    Fukui, Shoichi
    Sumiyoshi, Remi
    Igawa, Takashi
    Koga, Tomohiro
    Kawashiri, Shin-ya
    Aramaki, Toshiyuki
    Ichinose, Kunihiro
    Tamai, Mami
    Nakamura, Hideki
    Origuchi, Tomoki
    Eguchi, Katsumi
    Ueki, Yukitaka
    Kawakami, Atsushi
    JOURNAL OF BONE AND MINERAL METABOLISM, 2019, 37 (03) : 554 - 562